Solana Co — Director's Dealing 2017

Nov 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2017-11-09

Reporting Person: ANDREEFF DANE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-09	Class A Common Stock	P	33097	$2.704	Acquired	1285746	Indirect
2017-11-09	Class A Common Stock	P	7293	$2.704	Acquired	281405	Indirect
2017-11-09	Class A Common Stock	P	19610	$2.704	Acquired	671317	Indirect
2017-11-10	Class A Common Stock	P	45233	$2.5914	Acquired	1330979	Indirect
2017-11-10	Class A Common Stock	P	9967	$2.5914	Acquired	291372	Indirect
2017-11-10	Class A Common Stock	P	26800	$2.5914	Acquired	698117	Indirect
2017-11-13	Class A Common Stock	P	13790	$2.225	Acquired	1344769	Indirect
2017-11-13	Class A Common Stock	P	3039	$2.225	Acquired	294411	Indirect
2017-11-13	Class A Common Stock	P	8171	$2.225	Acquired	706288	Indirect

Footnotes

F1: The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP, and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F2: The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I, and as such may be deemed to beneficially own the securities held by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.

F3: The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I, and as such may be deemed to beneficially own the securities held by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.